Athira pharma to participate in sidoti december small cap investor conference

Company presentation to highlight novel therapeutic candidates targeting the hgf neurotrophic system in late-stage clinical development in neurodegenerative diseases, including alzheimer's disease company presentation to highlight novel therapeutic candidates targeting the hgf neurotrophic system in late-stage clinical development in neurodegenerative diseases, including alzheimer's disease
ATHA Ratings Summary
ATHA Quant Ranking